Alzheimer’s Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11(3):332–84.
Google Scholar
GBD. Disease and injury incidence and prevalence collaborators (2016) global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2015;388(10053):1545–602.
Google Scholar
Åkerborg Ö, Lang A, Wimo A, ei al (2016) Cost of dementia and its correlation with dependence. J Aging Health 28(8):1448–1464.
Scheltens P, Blennow K, Breteler MM, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–17.
CAS
PubMed
Google Scholar
Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532.
PubMed
Google Scholar
Verghese J, Wang C, Bennett DA, Lipton RB, Katz MJ, Ayers E. Motoric cognitive risk syndrome and predictors of transition to dementia: a multicenter study. Alzheimers Dement. 2019;15(7):870–7.
PubMed
PubMed Central
Google Scholar
Grande G, Rizzuto D, Vetrano DL, et al. Cognitive and physical markers of prodromal dementia: a 12-year-long population study. Alzheimers Dement. 2020;16(1):153–61.
PubMed
PubMed Central
Google Scholar
Aisen PS, Cummings J, Jack CR Jr, et al. On the path to 2025: understanding the Alzheimer's disease continuum. Alzheimers Res Ther. 2017;9(1):60.
PubMed
PubMed Central
Google Scholar
Frisoni GB, Boccardi M, Barkhof F, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Lancet Neurol. 2017;16(8):661–76.
PubMed
Google Scholar
Ossenkoppele R, Jansen WJ, Rabinovici GD, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313(10):1939–49.
PubMed
PubMed Central
Google Scholar
Jansen WJ, Ossenkoppele R, Knol DL, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015;313(19):1924–38.
PubMed
PubMed Central
Google Scholar
Grimmer T, Wutz C, Drzezga A, et al. The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment. Curr Alzheimer Res. 2013;10(1):82–5.
CAS
PubMed
Google Scholar
Wennberg AMV, Lesnick TG, Schwarz CG, et al. Longitudinal association between brain amyloid-Beta and Gait in the Mayo Clinic study of aging. J Gerontol A Biol Sci Med Sci. 2018;73(9):1244–50.
PubMed
Google Scholar
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9.
PubMed
PubMed Central
Google Scholar
Lauretani F, Maggio M, Ticinesi A, Tana C, Prati B, Gionti L, Nouvenne A, Meschi T. Muscle weakness, cognitive impairment and their interaction on altered balance in elderly outpatients: results from the TRIP observational study. Clin Interv Aging. 2018;13(4):1–7.
Folstein MF, Folstein SE, McHugh PR. "mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
CAS
PubMed
Google Scholar
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14.
CAS
PubMed
Google Scholar
Lyketsos CG, Miller DS, Neuropsychiatric Syndromes Professional Interest Area of the International Society to Advance Alzheimer’s Research and Treatment. Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes. Alzheimers Dement. 2012;8(1):60–4.
PubMed
Google Scholar
Ferrucci L, Bandinelli S, Cavazzini C, et al. Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease. Am J Med. 2004;116(12):807–15.
PubMed
Google Scholar
Caffarra P, Ghetti C, Concari L, Venneri A. Differential patterns of hypoperfusion in subtypes of mild cognitive impairment. Open Neuroimaging J. 2008;2:20–8.
Google Scholar
Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535–62.
PubMed
PubMed Central
Google Scholar
Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15(6):548–61.
CAS
PubMed
Google Scholar
Neri M, Rubichi S, DeVreese LP, Roth M, Cipolli C. Validation of the full and short forms of the CAMDEX interview for diagnosing dementia: evidence from a one-year follow-up study. Dement Geriatr Cogn Disord. 1998;9(6):339–46.
CAS
PubMed
Google Scholar
Vinkers DJ, Gussekloo J, Stek ML, Westendorp RG, Van Der Mast RC. The 15-item geriatric depression scale (GDS-15) detects changes in depressive symptoms after a major negative life event. The Leiden 85-plus study. Int J Geriatr Psychiatry. 2004;19(1):80–4.
PubMed
Google Scholar
Maggio M, Ceda GP, Ticinesi A, et al. Instrumental and non-instrumental evaluation of 4-meter walking speed in older individuals. PLoS One. 2016;11(4):e0153583.
PubMed
PubMed Central
Google Scholar
Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851–60.
PubMed
Google Scholar
Ferguson KJ, Cvoro V, MacLullich AMJ, et al. Visual rating scales of white matter Hyperintensities and atrophy: comparison of computed tomography and magnetic resonance imaging. J Stroke Cerebrovasc Dis. 2018;27(7):1815–21.
PubMed
PubMed Central
Google Scholar
Ruffini L, Lauretani F, Scarlattei M, et al. Integrating information from FDG - and amyloid PET for detecting different types of dementia in older persons. A case-series study. J Prev Alz Dis. 2016;3(3):127–32.
CAS
Google Scholar
Besson FL, La Joie R, Doeuvre L, et al. Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer's disease. J Neurosci. 2015;35(29):10402–11.
CAS
PubMed
PubMed Central
Google Scholar
Lauretani F, Ruffini L, Ticinesi A, Nouvenne A, Maggio M, Meschi T. Accuracy of quantitative positron emission tomography assessment for differentiating cerebral age-related from pathological amyloid deposition: a preliminary report from a case-series study. World J Nucl Med. 2018;17(2):106–11.
PubMed
PubMed Central
Google Scholar
Thurfjell L, Lilja J, Lundqvist R, Buckley C, Smith A, Vandenberghe R, Sherwin P. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. J Nucl Med. 2014;55(10):1623–8.
CAS
PubMed
Google Scholar
Wolk DA, Sadowsky C, Safirstein B, et al. Use of Flutemetamol F 18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment. JAMA Neurol. 2018. https://doi.org/10.1001/jamaneurol.2018.0894.
de Wilde A, van der Flier WM, Pelkmans W, et al. Association of Amyloid Positron Emission Tomography with changes in diagnosis and patient treatment in an unselected memory clinic Cohort: The ABIDE Project. JAMA Neurol. 2018. https://doi.org/10.1001/jamaneurol.2018.1346.
Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the Montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol. 2013;26(1):1–5.
PubMed
PubMed Central
Google Scholar
Juby A, Tench S, Baker V. The value of clock drawing in identifying executive cognitive dysfunction in people with a normal mini-mental state examination score. CMAJ. 2002;167(8):859–64.
PubMed
PubMed Central
Google Scholar
Saur R, Maier C, Milian M, Riedel E, Berg D, Liepelt-Scarfone I, Leyhe T. Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease. Dement Geriatr Cogn Disord. 2012;33(1):59–72.
CAS
PubMed
Google Scholar
Carare RO, Hawkes CA, Jeffrey M, Kalaria RN, Weller RO. Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol. 2013;39(6):593–611.
CAS
PubMed
Google Scholar
Morris AW, Sharp MM, Albargothy NJ, Fernandes R, Hawkes CA, Verma A, Weller RO, Carare RO. Vascular basement membranes as pathways for the passage of fluid into and out of the brain. Acta Neuropathol. 2016;131(5):725–36.
CAS
PubMed
PubMed Central
Google Scholar
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol. 2004;55(3):306–19.
CAS
PubMed
Google Scholar
Thal DR, Rüb U, Orantes M, Braak H. Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791–800.
PubMed
Google Scholar
Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA; Harvard Aging Brain Study (2018) Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in cognitively Normal older adults. Am J Psychiatry 175(6):530–537.
Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS, Alzheimer’s Disease Neuroimaging Initiative. Association between elevated brain amyloid and subsequent cognitive decline among cognitively Normal persons. JAMA. 2017;317(22):2305–16.
CAS
PubMed
PubMed Central
Google Scholar
Sepulcre J, Grothe MJ, Sabuncu M, Chhatwal J, Schultz AP, Hanseeuw B, El Fakhri G, Sperling R, Johnson KA. Hierarchical Organization of tau and Amyloid Deposits in the cerebral cortex. JAMA Neurol. 2017;74(7):813–20.
PubMed
PubMed Central
Google Scholar
Farrell ME, Kennedy KM, Rodrigue KM, Wig G, Bischof GN, Rieck JR, Chen X, Festini SB, Devous MD Sr, Park DC. Association of Longitudinal Cognitive Decline with amyloid burden in middle-aged and older adults: evidence for a dose-response relationship. JAMA Neurol. 2017;74(7):830–8.
PubMed
PubMed Central
Google Scholar
Hanseeuw BJ, Betensky RA, Jacobs HIL, et al. Association of Amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019. https://doi.org/10.1001/jamaneurol.2019.1424 [Epub ahead of print].
Fantoni E, Collij L, Alves IL, Buckley C, Farrar G. The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging. J Nucl Med. 2019. pii: jnumed.119.235879. doi: https://doi.org/10.2967/jnumed.119.235879. [Epub ahead of print].
Zwan MD, Bouwman FH, Konijnenberg E, et al. Diagnostic impact of [18F] flutemetamol PET in early-onset dementia. Alzheimers Res Ther. 2017. https://doi.org/10.1186/s13195-016-0228-4.
Pontecorvo MJ, Siderowf A, Dubois B, et al. Effectiveness of Florbetapir PET imaging in changing patient management. Dement Geriatr Cogn Disord. 2017;44(3–4):129–43.
PubMed
Google Scholar
Mallik A, Drzezga A, Minoshima S. Clinical amyloid imaging. Semin Nucl Med. 2017;47(1):31–43.
PubMed
Google Scholar
Rabinovici GD, Gatsonis C, Apgar C, et al. Association of Amyloid Positron Emission Tomography with Subsequent Change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321(13):1286–94.
PubMed
PubMed Central
Google Scholar